The Scientist - Home

Twenty years into the Psychedelic Renaissance, neuroscientists still struggle to understand how psychedelics work and how to rectify misconceptions about these drugs.

Lost and then recovered blood supply when limbs get compressed causes nerves to go haywire.

By spreading out tightly packed information in neural networks, a new set of tools could make AI protein models easier to understand. 

Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug development with RNA-based therapies.

Short peptides can self-assemble into net-like structures that kill bacteria. Now, researchers have discovered how to control and enhance this ability.

A new study recasts placental implantation as “coopetition,” showing how maternal and fetal cells both resist and enable invasion, with clues to pregnancy health.

A single-dose chlamydia vaccine could help koala populations bounce back from the devastating disease, preventing them from becoming functionally extinct.

Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and inform personalized medicine.

Making blood in the lab can be hard because scientists don’t know what triggers a key final step in red blood cell maturation. A new study may change that.

Investigating autophagy deficits in the amygdala, this postdoc explores new therapeutic strategies for treating chronic pain.

Emotional or rewarding experiences can preserve memories of concurrent ordinary events, offering insights into how the brain decides what to keep and what to forget.

Years before people develop rheumatoid arthritis, their blood teems with activated immune cells that could serve as biomarkers for early diagnosis.